FMC has announced planned retirement of Dr. Kathleen Shelton, executive VP and CTO, following a 33-year career in the chemical industry.
Dr. Seva Rostovtsev, director of Discovery Chemistry, has been elected VP and CTO by the board of directors.
Shelton and Rostovtsev will transition responsibilities as part of the succession plan during the next several months until her retirement on March 31, 2023.
Rostovtsev, who is a member of the R&D Leadership Team and currently reports to Shelton, will report to Mark Douglas, president and CEO, and will join the company’s operating committee.
Shelton joined FMC as CTO in 2017, where she has led the company’s global R&D strategy, overseen an innovation pipeline
